Orthofix Adds Two Key Executives
Orthofix International N.V. has appointed two key executives within the last month. Brad Mason took over the role of president and CEO in mid-March, and Emily Buxton was appointed chief financial officer (CFO) in early April.
Mason previously worked for Orthofix between 2003 and 2010 in roles of increasing seniority. He was reportedly instrumental in driving the company’s acquired spinal implants business to profitability. Mason joined the company upon the acquisition of Breg Inc., a Carlsbad, Calif.-based maker of orthopedic braces, which he founded in 1989. In addition, he was dj Orthopedics’ (formally DonJoy Inc.) first head of manufacturing operations and product design, where his efforts resulted in hundreds of new products during his tenure. Mason is also the named inventor on 38 issued patents in the orthopedic product arena.
Mason replaced Robert Vaters, who commented, “The company is now well positioned to resume its growth trajectory under Brad’s leadership.”
“The board believes that Brad is a terrific leader, who brings with him a strong track record of growth and value creation, and we welcome him back to Orthofix at a time when the company is in a fundamentally solid position,” said Orthofix’s Chairman James Gero. “We also want to thank [Robert] for his many contributions over the past several years guiding the company through difficult times and wish him well in his future endeavors.”
New CFO Emily Buxton has been with Orthofix’s corporate finance group since 2003 as a senior SEC (Securities and Exchange Commission) and consolidations accountant. After advancing to the position of vice president and controller, she served as CFO of global orthopedics for Orthofix from 2010 to the time of her appointment as interim CFO. Prior to joining Orthofix, Buxton worked for two large public companies in SEC reporting; prior to that she worked in public accounting. She received her Bachelor of Arts degree in accounting from Columbia College in Columbia, S.C.
“I am delighted to announce the appointment of Emily to this critical position, particularly at this time in Orthofix’s history when we are so well positioned for the future,” Mason said. “It will be my pleasure to work side by side with her and the rest of the executive team as we explore the many opportunities we have to define the Orthofix of tomorrow. Emily has successfully served in various financial roles of increasing responsibility since joining Orthofix in 2003. I believe her proven track record in financial management, global business experience, and strong understanding of every aspect of the company will help take us to the next level in driving value for our healthcare partners and shareholders.”
Orthofix is focused on repair and regenerative solutions to the spine and orthopedic markets. The company is headquartered in Lewisville, Texas.